Ipsos Share: 4.5% Gain Over the Quarter, Stock Up Another 2% During Trading Session
The polling and market research group is moving forward during the session, in a rising Paris market. This recovery comes after a month of decline and brings the stock back to a technical level that has been monitored for several weeks.
A Stock Returning to Its 200-Day Moving Average After a Month of Decline
The Ipsos share gains 2.22% to €35.86, while the SBF 120 advances 0.46%. This increase comes after a decline of 2.61% over one month and extends the fall of late September, when the stock tested the €34.56 zone. The price is now in contact with the 200-day MA (€35.82) and above the 20-day MA (€35.25), but remains below the 50-day MA (€37.54), at a distance of 4.48%.
The RSI at 40 remains neutral, with no signs of excess. Over the week, the gain is 1.76%, which shows that today's rebound is part of a gradual recovery rather than an isolated move. Support at €34.56 and resistance at €40.06 bound the stock's movement in the zone observed in recent weeks.
A P/E Ratio of 6.9 and a Share Buyback Program Executed at 48%
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
According to the consensus of analysts surveyed, the stock is valued at approximately 6.9 times current fiscal year earnings and 6.4 times next fiscal year earnings, with expected earnings per share growth of 8.4%. The group is also continuing to repurchase its own shares: the €57 million program announced on July 22 was executed at approximately 48% as of September 25, representing €27 million already repurchased. Over twelve months, buybacks reached €90 million, or 5.8% of market capitalization. The next milestones to follow are the continuation of this program and the analyst consensus, while the stock must still recover its 50-day MA at €37.54 to erase most of its month-long decline.
Dans ces conditions et malgré une hausse du carnet de commandes à la fin du premier semestre, le Groupe anticipe désormais une croissance organique autour de 2 %
Risks mentioned
Baisse des revenus due à des effets de change défavorables.
Impact négatif de la déconsolidation de la Russie.
Opportunities identified
Retour à la croissance organique positive de 0,8 % au S1.
Outlook / guidance
Expected revenue: 2 475 millions d'euros
Management commentary: le Groupe anticipe désormais une croissance organique autour de 2 %
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
